Eli Lilly and Company - Accumulated Depreciation

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Accumulated-Depreciation" stands at 12.41 Billion United States Dollars as of 09/30/2025.

As of the end of Eli Lilly and Company's third quarter, the item "Accumulated Depreciation" stands at 12.41 Billion USD. This represents a decrease of -1.14 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.03 percent compared to the value the year prior.
The 1 year change in percent is 5.03.
The 3 year change in percent is 23.20.

The Serie's long term average value is 9.41 Billion United States Dollars. It's latest available value, on 09/30/2025, is 31.96 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +1,244.04%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -1.14%.